Confluence Wealth Services Inc. Sells 88 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Confluence Wealth Services Inc. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 585 shares of the medical equipment provider’s stock after selling 88 shares during the quarter. Confluence Wealth Services Inc.’s holdings in Intuitive Surgical were worth $305,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. raised its stake in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at about $36,000. Finally, Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical in the third quarter worth about $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 28,843 shares of company stock valued at $15,357,560. 0.80% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 1.9 %

NASDAQ ISRG opened at $590.90 on Thursday. The firm’s 50 day simple moving average is $551.99 and its 200 day simple moving average is $512.04. The firm has a market capitalization of $210.47 billion, a price-to-earnings ratio of 92.18, a P/E/G ratio of 5.51 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ISRG. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Evercore ISI raised their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Citigroup upped their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Finally, Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.